Table 3.
Summaries of 5-year survival from study entry according to potential prognostic factors (23 deceased patients)
| Prognostic factors | n | 5-year survival percentages | P-value* |
|---|---|---|---|
| Gender | 0.7 | ||
| Women | 141 | 86 | |
| Men | 127 | 91 | |
| Age at diagnosis | 0.4 | ||
| 0-15 years | 22 | 81 | |
| 16-30 years | 59 | 92 | |
| 31-45 years | 115 | 89 | |
| 46-60 years | 61 | 82 | |
| >61 years | 11 | 100 | |
| Age at entry | 0.03 | ||
| 18-30 years | 32 | 91 | |
| 31-45 years | 85 | 94 | |
| 46-60 years | 104 | 89 | |
| >61 years | 47 | 77 | |
| Nationality | 0.7 | ||
| Netherlands | 99 | 90 | |
| Germany | 48 | 93 | |
| US | 69 | 85 | |
| UK | 20 | 67 | |
| Other° | 32 | 93 | |
| Disability level at study entry | 0.002 | ||
| No wheelchair use or respiratory support ª | 127 | 95 | |
| Wheelchair use | 34 | 91 | |
| Use of respiratory support | 39 | 89 | |
| Both wheelchair use and respiratory support | 68 | 74 | |
| RHS score at study entry* | 0.002 | ||
| 1 | 85 | 74 | |
| 2 | 85 | 95 | |
| 3 | 88 | 97 |
* Log rank test for the Kaplan-Meier curves, overall p-values of univariate analyses. ° Due to small groups Canada and Australia were classified into the category "other". ª 'Respiratory support 'includes partial and fulltime, invasive and non-invasive respiratory support. *RHS score was divided into tertiles for comparison. 1) < 23, 2) 23-30, 3)>30.